Literature DB >> 21221702

Is procalcitonin a marker of invasive bacterial infection in acute sickle-cell vaso-occlusive crisis?

K Stankovic Stojanovic1, O Steichen, F Lionnet, C Bachmeyer, I Lecomte, V Avellino, G Grateau, R Girot, G Lefevre.   

Abstract

Fever is often present during painful vaso-occlusive crisis (VOC) in sickle-cell disease (SCD), but does not always indicate infection. The aim of our study was to test procalcitonin as a marker of invasive bacterial infection in VOC. Consecutive SCD adults hospitalized for VOC were included. Data were collected at admission and within 24 h after the onset of fever. We distinguished patients with clinically defined and microbiologically documented invasive bacterial infection from patients with no evidence of invasive bacterial infection and who fared well without antibiotics. One hundred and twelve patients were enrolled (61% females, median age 23 years, 88% homozygous SCD). All patients with procalcitonin (PCT) level ≥1 μg/L had an invasive bacterial infection, but two patients (33%) with an invasive bacterial infection had a PCT level <1 μg/L. High levels of PCT indicate invasive bacterial infection. However, a single low PCT level without follow-up measurement cannot rule out an invasive bacterial infection and should not withhold the prescription of antibiotics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21221702     DOI: 10.1007/s15010-010-0072-6

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

1.  Procalcitonin is not produced by circulating blood cells.

Authors:  G Monneret; B Laroche; J Bienvenu
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  The architecture of diagnostic research.

Authors:  D L Sackett; R B Haynes
Journal:  BMJ       Date:  2002-03-02

Review 3.  Pathobiochemistry and clinical use of procalcitonin.

Authors:  Michael Meisner
Journal:  Clin Chim Acta       Date:  2002-09       Impact factor: 3.786

4.  Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection.

Authors:  E R Kuse; I Langefeld; K Jaeger; W R Külpmann
Journal:  Crit Care Med       Date:  2000-02       Impact factor: 7.598

Review 5.  Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis.

Authors:  H Tang; T Huang; J Jing; H Shen; W Cui
Journal:  Infection       Date:  2009-10-13       Impact factor: 3.553

6.  High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis.

Authors:  A Viallon; F Zeni; C Lambert; B Pozzetto; B Tardy; C Venet; J C Bertrand
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

7.  Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study.

Authors:  P Hausfater; S Garric; S Ben Ayed; M Rosenheim; M Bernard; B Riou
Journal:  Clin Infect Dis       Date:  2002-02-19       Impact factor: 9.079

8.  Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin.

Authors:  F M Brunkhorst; O K Eberhard; R Brunkhorst
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

Review 9.  A framework for clinical evaluation of diagnostic technologies.

Authors:  G H Guyatt; P X Tugwell; D H Feeny; R B Haynes; M Drummond
Journal:  CMAJ       Date:  1986-03-15       Impact factor: 8.262

10.  Serum procalcitonin concentration as a negative predictor of serious bacterial infection in acute sickle cell pain crisis.

Authors:  L Keith Scott; Laurie R Grier; Thomas C Arnold; Steven A Conrad
Journal:  Med Sci Monit       Date:  2003-10
View more
  5 in total

1.  Does Procalcitonin Predict Bacterial Infection in Febrile Children with Sickle Cell Disease?

Authors:  Narcisse Elenga; Lenaic Placide; Emma Cuadro-Alvarez; Laurence Long; Falucar Njuieyon; Elise Martin; Rémi Kom-Tchameni; Antoine Defo; Sitraka Herinantenaina Razafindrakoto; Yajaira Mrsic; Mathieu Nacher
Journal:  Indian J Pediatr       Date:  2018-06-23       Impact factor: 1.967

2.  Evaluation of potential biomarkers for the discrimination of bacterial and viral infections.

Authors:  P Chalupa; O Beran; H Herwald; N Kaspříková; M Holub
Journal:  Infection       Date:  2011-07-01       Impact factor: 3.553

3.  Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening.

Authors:  K Saeed; M Dryden; A Sitjar; G White
Journal:  Infection       Date:  2013-05-04       Impact factor: 3.553

4.  Procalcitonin as a biomarker of bacterial infection in sickle cell vaso-occlusive crisis.

Authors:  Dilip Kumar Patel; Manoj Kumar Mohapatra; Ancil George Thomas; Siris Patel; Prasanta Purohit
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-17       Impact factor: 2.576

5.  Procalcitonin levels in fresh serum and fresh synovial fluid for the differential diagnosis of knee septic arthritis from rheumatoid arthritis, osteoarthritis and gouty arthritis.

Authors:  Chenggong Wang; DA Zhong; Qiande Liao; Lingyu Kong; Ansong Liu; Han Xiao
Journal:  Exp Ther Med       Date:  2014-07-29       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.